Emdeon (EM) Shareholder Lawsuit




Emdeon Inc. (NYSE: EM) is being sold to Blackstone Capital Partners for almost $3 billion, taking EM, a health-care billing firm private again after two years as a public company. Under the terms of the deal, Emdeon shareholders will receive $19.00 in cash for each share of Emdeon common stock they own. Shareholders General Atlantic and Hellman & Freidman have agreed to tender their shares, which represent approximately 70% of the Company’s outstanding shares.

From reports it appears that the deal favors insiders because of the votes locked up of Great Atlantic and Hellman Friedman (about 70%), thus small shareholders will have no vote. It appears management is poised to make tens of millions from options, rolling over their equity and staying at their jobs, do they care about getting a higher price? Do they care about this company?

Our Law firm wants to find out if the Emdeon Board of Directors breached their fiduciary duties to Emdeon stockholders by failing to adequately shop the Company before entering into this transaction and whether Blackstone Capital Partners VI L.P. is underpaying for Emdeon shares. An analyst set a price target of $21.00 per Emdeon share.

Emdeon Sale Unfair? Going Private
If you own any shares of EM call us now.

Kyros Law is investigating the fairness of the proposed transaction to EM shareholders, whether the shareholders are being underpaid for their stock. The acquisition will be one of Blackstone’s biggest corporate buyouts since 2008 and it is one of the largest public-to-private deals announced by buyout firms this year.

If you are a shareholder of any amount of EM please call Attorney Bill Kyros at 1-800-934-2921 to discuss your rights.

Kyros Law is a Boston-based law firm with significant experience representing investors in merger-related shareholder class actions, shareholder derivative actions, and securities fraud class actions. For info about our law firm please ourKyros Law web site. see also our Merger Lawsuit Page.